Evaluation of the Asparagine Synthetase Level in Leukemia Cells by Monoclonal Antibodies

被引:3
|
作者
Kusano-Arai, Osamu [4 ]
Iwanari, Hiroko
Mochizuki, Yasuhiro
Nakata, Hiromi
Kodama, Tatsuhiko [2 ]
Kitoh, Toshiyuki [3 ]
Hamakubo, Takao [1 ]
机构
[1] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Mol Biol & Med, Meguro Ku, Tokyo 1538904, Japan
[2] Univ Tokyo, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med, Tokyo 1538904, Japan
[3] Aichi Med Univ, Dept Pediat, Nagakute, Aichi 48011, Japan
[4] Inst Immunol Co Ltd, Bunkyo Ku, Tokyo, Japan
来源
HYBRIDOMA | 2012年 / 31卷 / 05期
关键词
ACUTE LYMPHOBLASTIC-LEUKEMIA; EXPRESSION LEVELS; CYCLE ARREST; RESISTANCE; SENSITIVITY; BACULOVIRUS; PROTEINS; CANCER; LINES;
D O I
10.1089/hyb.2012.0014
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
L-Asparaginase (ASNase) is important for the treatment of childhood acute lymphoblastic leukemia. ASNase sensitivity has been shown to correlate with the asparagine synthetase (ASNS) protein content in acute lymphoblastic leukemia cell lines. However, there have been few studies to determine ASNS protein levels in human leukemias, since no appropriate monoclonal antibody is available for such quantitative analysis. In this study, we report the generation of anti-ASNS monoclonal antibodies, which are applicable to flow cytometry and enzyme-linked immunosorbent assay. These monoclonal antibodies should provide a valuable tool for the quantification of ASNS protein level and estimation of ASNase-resistance in leukemia cells.
引用
收藏
页码:325 / 332
页数:8
相关论文
共 50 条
  • [31] EVALUATION OF PROLIFERATING CELLS IN ACUTE-LEUKEMIA WITH ANTIBODIES TO PROLIFERATING CELL NUCLEAR ANTIGEN AND KI-67 MONOCLONAL-ANTIBODIES
    INOUE, T
    YAMANE, T
    PARK, K
    IM, T
    TATSUMI, N
    OKUDA, K
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1993, 117 (10) : 969 - 972
  • [32] A sulfoximine-based inhibitor of human asparagine synthetase kills L-asparaginase-resistant leukemia cells
    Ikeuchi, Hideyuki
    Ahn, Yong-Mo
    Otokawa, Takuya
    Watanabe, Bunta
    Hegazy, Lamees
    Hiratake, Jun
    Richards, Nigel G. J.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (19) : 5915 - 5927
  • [33] MONOCLONAL-ANTIBODIES IN LEUKEMIA AND LYMPHOMA
    不详
    LANCET, 1982, 1 (8280): : 1055 - 1056
  • [34] Monoclonal antibodies in acute lymphoblastic leukemia
    Jabbour, Elias
    O'Brien, Susan
    Ravandi, Farhad
    Kantarjian, Hagop
    BLOOD, 2015, 125 (26) : 4010 - 4016
  • [35] LEUKEMIA TYPING WITH MONOCLONAL-ANTIBODIES
    FINK, PC
    FREITAG, U
    HAECKEL, R
    BLUT, 1985, 51 (03): : 215 - 215
  • [36] MONOCLONAL ANTIBODIES IN ACUTE LYMPHOBLASTIC LEUKEMIA
    Jabbour, Elias
    Kantarjian, Hagop
    LEUKEMIA RESEARCH, 2016, 49 : S7 - S7
  • [37] Monoclonal antibodies in the treatment of lymphoid leukemia
    O'Brien, S
    Giles, FJ
    DRUGS OF TODAY, 2003, 39 (07): : 541 - 550
  • [38] The Role of Monoclonal Antibodies in the Management of Leukemia
    Al-Ameri, Ali
    Cherry, Mohamad
    Al-Kali, Aref
    Ferrajoli, Alessandra
    PHARMACEUTICALS, 2010, 3 (10): : 3258 - 3274
  • [39] MONOCLONAL ANTIBODIES IN ACUTE LYMPHOCYTIC LEUKEMIA
    Jabbour, Elias
    LEUKEMIA RESEARCH, 2017, 61 : S4 - S4
  • [40] Monoclonal antibodies in chronic lymphocytic leukemia
    Ferrajoli, Alessandra
    Faderl, Stefan
    Keating, Michael J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (09) : 1231 - 1238